The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients
NCT02297620
·
clinicaltrials.gov ↗
COMPLETED
Status
8687
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
Suglat®
Sponsor
Astellas Pharma Inc